1[2]SHTHERLAND D E,WEITZ I C,LIEBMAN H A.Thromboembolic complications of cancer:epidemiology,Pathogenesis,diagnosis,and treantment[J].Am J Hematol,2003,72(1):43-52.
2[3]LUXEMBOURG B,BAUERSACHS R.malignancy and thrombosis:a double-sided clinical relationship[J].Vasa,2005,34(4):225-234.
3[4]BARON J A,GRIDLEY G,WEIDERPASS E,et al.Venous thromboembolism and cancer[J].Lancet,1998,351(9109):1007-1080.
4[5]THODIYIL P A,KAKKAR A K.Variation in relative risk of venous thromboembolism in different cancers[J].Thromb Haemost,2002,87(6):1067-1077.
5[6]ROSOVSKY R P,KUTER D J.Catheter-related thrombosis in cancer patients:pathophysiology,diagnosis,and management[J].Hematol Oncol Clin North Am,2005,19(1):183-202.
6[7]SHOJI M,HANCOCK W W,ABE K,et al.Activation of coagulation and angiogensis in cancer;immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer[J].Am J Pathol,1998,152(2):399-411.
7[8]LEVI M.Systemic microangiopathies in the cancer patients[M]//Lugassy G,Fanlanga A,Kakkar A,et al.Thrombosis and cancer.London:Taylor & Francis,2004:117-127.
8[9]GORDON L I,KWAAN H C.Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cander patient[J].Semin Thromb Hemost,1999,25(2):217-221.
2Kim HK,Song KS,Lee KR,et al.Comparison of plasma D-dimer and thrombus precursor protein in patients with operable breast cancer as a potential predictor of lymph node metastasis.Blood Coagul Fibrinolysis,2004,15:9-13.
